发明名称 IMMUNOCONJUGATE, A METHOD OF AN IMMUNOCONJUGATE PREPARING AND A PHARMACEUTICAL COMPOSITION
摘要 FIELD: biochemistry, medicine, oncology, pharmacy. SUBSTANCE: immunoconjugate is a monoclonal antibody or its fragment connected with biologically active ligand. Antibody or its fragment is directed against tumor cell carrying an antigenic epitope of epidermal growth factor receptor. Cytokine is used as a biologically active ligand. For preparing an immunoconjugate DNA sequence encoding antibody or its fragment is fused with DNA sequence encoding a biologically active ligand. Obtained structure is introduced in an expression vector which is cultured in host cells. Invention related to new fused protein can be used for treatment of patients with tumor diseases being with any tumors species. EFFECT: improved method of preparing, enhanced effectiveness of an immunoconjugate obtained. 13 cl, 10 dwg, 2 tbl
申请公布号 RU2129018(C1) 申请公布日期 1999.04.20
申请号 RU19940045281 申请日期 1994.12.23
申请人 MERK PATENT GMBKH 发明人 ILKA FON KHEGEN;UVE KHOFMANN;KARLOTTA-SIL'VIJA EGGLE;VOL'FGANG SHTRITTMATTER;JORG SHTADL'MJULLER;ZIGFRID MATTSKU
分类号 C12N15/09;A61K;A61K38/00;A61K38/16;A61K38/18;A61K38/19;A61K38/20;A61K39/00;A61K39/295;A61K39/395;A61K39/44;A61K47/48;A61P35/00;A61P35/04;C07K;C07K14/52;C07K14/525;C07K14/54;C07K14/55;C07K16/00;C07K16/28;C07K16/30;C07K16/42;C07K16/46;C07K19/00;C12N;C12N15/13;C12N15/19;C12N15/55;C12N15/62;C12N15/64;C12N15/72;C12N15/79;C12P21/02;C12P21/08;C12R1/19;C12R1/91;(IPC1-7):A61K47/48 主分类号 C12N15/09
代理机构 代理人
主权项
地址